TSX:TLRY (Aphria)
About TLRY
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Aphria (TSX: TLRY) Latest News

Cannabis Stocks
Should You Buy Tilray (TSX:TLRY) After its 1st-Quarter Performance?

Tech Stocks
TSX Today: Top 3 Canadian Stocks to Watch on Thursday, October 7

Energy Stocks
Got $1,000? 3 Top Under-$20 Canadian Stocks to Buy Right Now

Cannabis Stocks
Cannabis Selloff: 3 Weed Stocks to Avoid and 1 Must-Buy

Cannabis Stocks
3 Cannabis Stocks to Buy Before the Next Boom

Tech Stocks
4 Canadian Stocks That Can Deliver Multi-Fold Returns in the Long Term

Tech Stocks
4 Under-$15 Canadian Stocks to Buy Right Now

Cannabis Stocks
2 Weed Stocks With Shocking Declines of Up to 40%

Dividend Stocks
5 High-Growth TSX Stocks That Have Recently Fallen More Than 20%

Cannabis Stocks
Cannabis Stocks: If the Rally Isn’t Over, This 1 Looks Attractive

Tech Stocks
3 Top Canadian Stocks Trading at Discounts of Over 40%
